Related Experiment Videos
Status epilepticus. A perspective from the neuroscience intensive care unit
1St. Bernardine Neuroscience Center, San Bernardino, California.
Neurosurgery Clinics of North America
|October 1, 1994
Summary
Early diagnosis and treatment of status epilepticus (SE) are crucial for preventing brain injury. Access to timely treatment, especially in emergency departments, remains a significant challenge that must be addressed to improve patient outcomes.
Area of Science:
- Neurology
- Critical Care Medicine
Background:
- Status epilepticus (SE), encompassing generalized convulsive SE (GCSE) and non-convulsive SE (NCSE), frequently presents in emergency departments and NICUs.
- While GCSE is common in emergency departments, NCSE is more prevalent in NICUs. GCSE can evolve into NCSE due to prolonged seizures or incomplete treatment.
Observation:
- Acute cerebral injuries are common in SE patients, irrespective of prior epilepsy history, and are almost definitional in NICU patients.
- SE progresses through stages, potentially leading to refractory SE, neuronal necrosis, and permanent brain damage.
- Treatment responsiveness is time-dependent, highlighting the critical 60-minute window for effective SE control.
Findings:
- Access to SE treatment protocols is a critical, overlooked barrier to improving outcomes, particularly in emergency settings.
- Early diagnosis in NICUs, often requiring a high index of suspicion and continuous EEG monitoring for NCSE, is key as access is less problematic.
- NICU patients may be more vulnerable to SE due to pre-existing cerebral injuries, making expedited treatment imperative.
Implications:
- Addressing access barriers in emergency departments is essential for optimizing SE treatment algorithms.
- Prompt diagnosis and management, including supportive care and appropriate first-line medications like lorazepam or diazepam-phenytoin, are vital.
- High-dose intravenous midazolam shows promise as an alternative for refractory SE, complementing established treatments like barbiturate coma.